Oral amiodarone and atrial fibrillation.
Tahapary
G J
GJ
Suttorp
M J
MJ
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000209:etiology / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D006801:Humans; D018579:Patient Selection; D011433:Propranolol / Q000627:therapeutic use*; D013015:Sotalol / Q000627:therapeutic use*; D013617:Tachycardia, Supraventricular / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011433:Propranolol; D013015:Sotalol; D000638:Amiodarone